Immuron Earnings Estimate
| IMRN Stock | USD 0.81 0.03 2.98% |
Immuron Earnings per Share Projection vs Actual
About Immuron Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Immuron earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Immuron estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Immuron fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -74.2 M | -70.5 M | |
| Earnings Yield | (0.43) | (0.45) | |
| Price Earnings Ratio | (2.43) | (2.55) | |
| Price Earnings To Growth Ratio | 0.09 | 0.10 |
Pair Trading with Immuron
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immuron position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immuron will appreciate offsetting losses from the drop in the long position's value.Moving together with Immuron Stock
Moving against Immuron Stock
| 0.9 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.69 | DSGN | Design Therapeutics | PairCorr |
| 0.69 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.66 | ENGN | enGene Holdings Common | PairCorr |
| 0.49 | 63E | ONWARD MEDICAL BV | PairCorr |
The ability to find closely correlated positions to Immuron could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immuron when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immuron - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immuron Ltd ADR to buy it.
The correlation of Immuron is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immuron moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immuron Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immuron can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuron Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Will Biotechnology sector continue expanding? Could Immuron diversify its offerings? Factors like these will boost the valuation of Immuron. Market participants price Immuron higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Immuron data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.63) | Revenue Per Share | Quarterly Revenue Growth 0.293 | Return On Assets | Return On Equity |
Understanding Immuron Ltd ADR requires distinguishing between market price and book value, where the latter reflects Immuron's accounting equity. The concept of intrinsic value - what Immuron's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Immuron's price substantially above or below its fundamental value.
Please note, there is a significant difference between Immuron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immuron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Immuron's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.